Spero L
Neurochem Res. 1985 Jun;10(6):755-65. doi: 10.1007/BF00964533.
We have shown that diazepam (ED50 2.4 microM), flunitrazepam (ED50 10.2 microM) and Ro5-4864 (ED50 5 microM) are able to enhance both total and specific [3H]phenytoin binding. Picrotoxin (IC50 1.43 microM) and chloride, either NaCl or KCl (IC50 42.4 microM) inhibit both the increase in total and specific binding of [3H]phenytoin, Ro15-1788 does not. The optimum time for this enhancement was 3-4 hours. While the ED50's for the benzodiazepines are high their order of potency suggests that an involvement of both the "peripheral type" benzodiazepine receptor and the GABA-chloride ionophore complex is likely. Clonazepam (IC50 23 microM), oxazepam (IC50 12 microM) chlordiazepoxide (IC50 35 microM) and Ro8682-10, a convulsant benzodiazepine (IC50 16 microM) all inhibit both total and specific [3H]phenytoin binding. These effects were not blocked by chloride ions, picrotoxin or Ro 15-1788, and reached equilibrium within 45 minutes. This order of potency also parallels that for the "peripheral' benzodiazepine receptor in rat brain. These data suggest the presence of a micromolar benzodiazepine receptor site which may play a role in the control of CNS excitability. Nitrazepam, medazepam, bromazepam and the tetralobenzodiazepines U38335, U42794, U43434, and U37834 had no effect on total or specific [3H]phenytoin binding nor on the actions of the other benzodiazepines described in concentrations up to 50 microM.
我们已经表明,地西泮(半数有效量为2.4微摩尔)、氟硝西泮(半数有效量为10.2微摩尔)和Ro5-4864(半数有效量为5微摩尔)能够增强总的和特异性的[3H]苯妥英结合。印防己毒素(半数抑制浓度为1.43微摩尔)以及氯化物,无论是氯化钠还是氯化钾(半数抑制浓度为42.4微摩尔),均抑制[3H]苯妥英总的和特异性结合的增加,而Ro15-1788则无此作用。这种增强作用的最佳时间为3至4小时。虽然苯二氮䓬类药物的半数有效量较高,但其效价顺序表明“外周型”苯二氮䓬受体和GABA-氯离子载体复合物可能均参与其中。氯硝西泮(半数抑制浓度为23微摩尔)、奥沙西泮(半数抑制浓度为12微摩尔)、氯氮䓬(半数抑制浓度为35微摩尔)以及一种惊厥性苯二氮䓬Ro8682-10(半数抑制浓度为16微摩尔)均抑制总的和特异性的[3H]苯妥英结合。这些作用不受氯离子、印防己毒素或Ro 15-1788的阻断,且在45分钟内达到平衡。这种效价顺序也与大鼠脑中“外周”苯二氮䓬受体的顺序相似。这些数据表明存在一个微摩尔级的苯二氮䓬受体位点,其可能在中枢神经系统兴奋性的控制中发挥作用。硝西泮、美达西泮、溴西泮以及四氢苯二氮䓬类药物U38335、U42794、U43434和U37834在浓度高达50微摩尔时,对总的或特异性的[3H]苯妥英结合以及其他所述苯二氮䓬类药物的作用均无影响。